aod9604 human clinical trial weight loss results kg or percent AOD-9604 Results: Week-by-Week Timeline (2026) AOD9604 versus GLP-1 safety comparison
AOD9604 versus GLP 1 safety comparison Consensus 70 pounds. That's the average weight loss adults with obesity saw on the highest dose of an investigational once weekly Lilly medicine in a new Phase 3 study over 18 months. Nearly PDF] Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans Semantic Scholar Best Peptides for Weight Loss Ranked (2026) AOD 9604 Peptide for Weight Loss: Weight Loss and Vitality: Medical Weight Loss
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


